Spot on!! PM!!!Linda and Les are kidding themselves if they think for one minute they’re a stand alone just because they have a few patents for a new process!!!Practically speaking, the very best Northwest can do is a BP partnership that will extend their “shelf life” a few years or a buyout in the $5 to $7 range!! Long before DCVax Direct can be approved, mRNA vaccines will blow them out of the park!! Not being pessimistic, just being realistic!!! DCVax-L has a very limited market, very expensive and exhaustive ramp up process with tandem costs for Direct trials that will drain the company of any and all resources!!! BP knows this and will simply wait them out!!! Remember, Linda and Les are lawyers. Northwest is not a real company, only a patent holding company in search of royalties!! Everyday that passes , Northwest’s value is declining as the new wave immunotherapies are catching up!!! That’s why no one is really interested in Northwest.
Market Data 
Markets 
